Edition:
United States

Accuray Inc (ARAY.O)

ARAY.O on Nasdaq

4.55USD
28 Apr 2017
Change (% chg)

$-0.05 (-1.09%)
Prev Close
$4.60
Open
$4.10
Day's High
$4.55
Day's Low
$4.06
Volume
1,704,802
Avg. Vol
819,250
52-wk High
$6.39
52-wk Low
$4.06

Latest Key Developments (Source: Significant Developments)

Accuray Inc closes $70 million straight debt financing
Tuesday, 12 Jan 2016 06:30am EST 

Accuray Inc:Closes $70 million straight debt financing.Says net proceeds of loan to be used, in addition to $30 million of cash funded by Accuray, to retire $100 million of convertible notes.  Full Article

Accuray Inc Reaffirms FY 2016 guidance
Thursday, 29 Oct 2015 04:01pm EDT 

Accuray Inc:Reaffirms its financial guidance for FY 2016 on total revenue of $395 million to $410 million and adjusted EBITDA of $25 million to $35 million.FY 2016 revenue of $402 million - Thomson Reuters I/B/E/S.  Full Article

Accuray Inc names Kevin Waters as CFO
Tuesday, 15 Sep 2015 04:05pm EDT 

Accuray Inc:Kevin Waters named CFO of Accuray.Says lichtwardt will continue in a consulting role with the company for an interim period.Kevin waters succeeds Gregory E. Lichtwardt.Says waters joined Accuray as its senior vice president, Finance, in October, 2013.  Full Article

Accuray Incorporated gives FY 2016 guidance; EBITDA guidance above analysts' estimates
Thursday, 20 Aug 2015 04:01pm EDT 

Accuray Incorporated:Expects FY 2016 revenue to be in the range of $395 million to $410 million.Expects FY 2016 adjusted EBITDA to be in the range of $25 million to $35 million.FY 2016 revenue of $408 million and EBITDA of $10 million - Thomson Reuters I/B/E/S.  Full Article

Accuray Incorporated and RaySearch announces long term collaboration agreement regarding RayCare oncology information system
Monday, 13 Jul 2015 05:30am EDT 

Accuray Incorporated:Says that the company and RaySearch Laboratories AB (publ) announced they have signed a long term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.Says under the contract, Accuray will have the opportunity to offer RayCare in several designated major radiation therapy markets, making available a fully-integrated solution with the TomoTherapy and CyberKnife System product portfolios.RaySearch, known for its treatment planning software, RayStation and Accuray, recognized for tumor treatments.  Full Article

More From Around the Web

BRIEF-Accuray Q3 loss per share $0.06

* Accuray Inc - gross product orders totaled $83.8 million for 2017 fiscal Q3 compared to $56.4 million for prior fiscal year period